The next EACPT Focus Meeting will be held from 6th to 9th
October, 2016 in partnership with the Croatian Society for Clinical Pharmacology and Therapeutics.
The theme of the meeting is “How to Assess Medicines from Research to
Clinical Practice”.
There will be a bursary fund of 10,000 € to support abstract presenters.
There will be a bursary fund of 10,000 € to support abstract presenters.
Key dates
The main objectives of this Focus Meeting are
to increase awareness, knowledge and use of critical assessment
pillars for medicinal products in everyday clinical practice in order
to improve healthcare outcomes in affordable manner.
The meeting
will include a combination of scientific podium lectures, interactive workshops
and guided poster sessions covering three main pillars important for the
critical assessment of medicinal products - efficacy, effectiveness, and
economics (3E assessment).
There will be a dedicated session for Young Pharmacologists during the meeting. There will be an EACPT Scientific Communication Award for the best presentation by a young scientist.
There will be a dedicated session for Young Pharmacologists during the meeting. There will be an EACPT Scientific Communication Award for the best presentation by a young scientist.
Confirmed speakers and topics
JANNE TAPIO BACKMAN (Finland): Clinical drug-drug interaction studies:
methods, pitfalls and interpretation
NADA BOŽINA (Croatia): The role of pharmacogenetics in individulized
treatment choices
YLVA BOTTIGER (Sweden): National model for the introduction and
follow-up of new, expensive drugs in Sweden
GONZALO CALVO (Spain): Accelerated approval paths. What they do mean and
what they should not mean?
SIMON MAXWELL (UK): Safe introduction of new medicines into clinical
practice
KEN PATERSON (UK): Rapid Health Technology Assessment of New Medicines -
Lessons from 15 Years Experience in Scotland
WORKSHOP 2: EXCELLENCE IN CLINICAL RESEARCH - CLINICAL TRIAL DESIGN
IGOR FRANCETIĆ (Croatia): Effectiveness assessment: when
pharmacokinetics makes a difference / macrolide and azalide examples
MATTHIAS SCHWAB (Germany): Pharmacogenomics and drug response: future
challenges
EDUARDO SPINA (Italy): Efficacy of antidepressants: issues related to
bias in clinical trials
TABASSOME SIMON (France): Key points for building succesful clinical
trial
SINIŠA TOMIĆ (Croatia): The Role of the National Competent Authority
(NCA) in the Assessment of Medicinal Products in the National Procedure
DONALD SINGER (UK): Personalised medicine approaches for identifying
effective therapies
SLOBODAN VUKIČEVIĆ (Croatia): Current challenges and hurdles in new drug
development
We will be guests in the Adriatic coastal
town Opatija, Croatia. Opatija lies at the centre of the Kvarner
Riviera with the longest tradition of providing quality conference
venues in Croatia. Opatija’s very attractive geographic location,
lush green scenery and a pleasant climate (45° 20’ north
latitude) were some of the main reasons for its origins and the rapid development
of its tourism from the end of the 19th century. The venue – Grand Hotel 4 Opatijska Cvijeta – is
located in the very centre of Opatija and includes four
buildings that were named after Opatija’s best-known flowers. The
hotel has 223 rooms. The hotel also includes the large Tamaris
congress centre, which has 7 multi-functional halls and the latest
congress equipment.
Anyone from anywhere in the world with a professional interest in clinical pharmacology
and therapeutics can now join the EACPT as an Individual Associate member.
Membership benefits include:
Anyone from anywhere in the world with a professional interest in clinical pharmacology
and therapeutics can now join the EACPT as an Individual Associate member.
Membership benefits include:
- Discounted registration fees for EACPT meetings
- Online access to the Official EACPT Journal - Clinical Therapeutics
- Access to the EACPT’s worldwide network of Individual Associate Members
- Active involvement in EACPT
The EACPT was founded 24 years ago and now includes as members all
national organisations for clinical pharmacology in Europe, as well as
organisations from further afield internationally. The EACPT aims to provide
educational and scientific support for the more than 4000 individual
professionals interested in clinical pharmacology and therapeutics throughout
the European region, with its congresses attended by a global audience. The
EACPT also advises policy makers on how the specialty can contribute to human
health and wealth.
